Release Date: 04/10/18 08:34 Summary: Ceasing to be a substantial holder Price Sensitive: No Download Document 302.18KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%